tirbanibulin

tirbanibulin (KLISYRI) is an FDA-listed pharmaceutical active ingredient. Associated with S.A.. Route of administration: topical. Current US regulatory status: approved.

KLISYRI is a marketed brand name for tirbanibulin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

tirbanibulin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.